NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2) - ANVISA Registration 10071770898

Access comprehensive regulatory information for NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10071770898 and manufactured by manufacturer not specified. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Dec 02, 2029.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including ABBOTT RAPID DIAGNOSTICS JENA GMBH, ROCHE MOLECULAR SYSTEMS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
3 Competitors
10071770898
2 Related Devices
Registration Details
ANVISA Registration Number: 10071770898
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10071770898

25351784919201820

50248780000161

Company Information

Dates and Status

Dec 02, 2019

02/12/2029

09/18/2025 19:00:01

Registration Details

10071770898

25351784919201820

50248780000161

Company Information

Germany
PT: ALEMANHA

Dates and Status

Dec 02, 2019

02/12/2029

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2)"